AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graif, M.
Right arrow Articles by Young, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graif, M.
Right arrow Articles by Young, I. R.

American Journal of Neuroradiology, Vol 6, Issue 6 855-862, Copyright © 1985 by American Society of Neuroradiology


ARTICLES

Contrast-enhanced MR imaging of malignant brain tumors

M Graif, GM Bydder, RE Steiner, P Niendorf, DG Thomas and IR Young

Magnetic resonance (MR) imaging was performed before and serially after intravenous injection of 1 mmol/kg gadolinium-DTPA (Schering) in 17 patients with clinical and histologic diagnosis of malignant cerebral tumors. There was a decrease of 1% in T1 and 10% in T2 in normal white matter and a decrease of 8% in T1 and 14% in T2 in normal gray matter. Contrast enhancement was observed in 16 of the 17 tumors. In the region of maximal enhancement a mean decrease of 16% in T1 was observed in low- grade gliomas, a mean decrease in T1 of 29% was seen in high-malignancy gliomas, and a mean decrease in T1 of 33% was observed in metastases. The decreases in T1 persisted for at least 50 min. In one case the central cystic region of the tumor displayed a decrease in T1 and T2. Measurements of signal intensity displayed maximal contrast enhancement with an IR 1500/500/44 sequence, much less with SE 1500/44, and least with SE 1500/80. Edema was observed on precontrast images in 14 cases, but satisfactory definition of the tumor-edema margin was only possible in four cases. After contrast enhancement this margin was defined in 10 cases. In four of the 17 cases areas of apparent "edema" seen before administration of Gd-DTPA displayed significant contrast enhancement and probably represented tumor infiltration. Comparison with CT showed a greater degree of contrast enhancement on MR images in eight cases, an equal degree in eight cases, and greater enhancement on CT in one case.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Arch SurgHome page
S. Tezelman, Y. Giles, F. Tunca, K. Gok, A. Poyanli, A. Salmaslioglu, and T. Terzioglu
Diagnostic Value of Dynamic Contrast Medium Enhanced Magnetic Resonance Imaging in Preoperative Detection of Thyroid Carcinoma
Arch Surg, November 1, 2007; 142(11): 1036 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
P. Hou, K. M. Hasan, C. W. Sitton, J. S. Wolinsky, and P. A. Narayana
Phase-Sensitive T1 Inversion Recovery Imaging: A Time-Efficient Interleaved Technique for Improved Tissue Contrast in Neuroimaging
AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1432 - 1438.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
W Mukonoweshuro, A Herwardkar, and A Jackson
Imaging of intracranial tumours
Imaging, October 1, 2002; 14(5): 380 - 395.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
G. Moonis, J. Liu, J. K. Udupa, and D. B. Hackney
Estimation of Tumor Volume with Fuzzy-Connectedness Segmentation of MR Images
AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 356 - 363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. I. Grossman
BRAIN IMAGING
AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 9 - 18.
[Full Text] [PDF]